Watchlist Price Alert

CTI BioPharma Corp. (CTIC)

NASDAQ: CTIC · Real-Time Price · USD

9.10

0.01 (0.11%)

At close: Jun 23, 2023, 7:58 PM

CTI BioPharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-92.99M	-97.91M	-52.45M	-40.02M	-29.35M	-40.83M	-52.95M
Depreciation & Amortization	1.95M	526K	532K	546K	593K	717K	831K
Stock-Based Compensation	10.03M	4.74M	4.32M	5.17M	n/a	n/a	n/a
Other Working Capital	464K	2.28M	2.27M	-5.91M	-1.83M	-2.96M	-5.96M
Other Non-Cash Items	7.74M	-113K	3.62M	59K	-4.39M	1.24M	-29.31M
Deferred Income Tax	n/a	n/a	4.2M	-1.33M	n/a	n/a	n/a
Change in Working Capital	-7.92M	7.86M	-2.42M	7.76M	-13.04M	-6.17M	-8.58M
Operating Cash Flow	-81.19M	-84.89M	-42.2M	-27.82M	-39.82M	-39.3M	-76.68M
Capital Expenditures	-25M	n/a	-17K	n/a	-33K	-49K	-137K
Cash Acquisitions	25M	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-88.85M	n/a	-12.1M	-11.02M	-42.07M	n/a	n/a
Sales Maturities Of Investments	40M	12M	2.5M	39.15M	11.61M	11K	n/a
Other Investing Acitivies	-25M	n/a	n/a	n/a	n/a	11K	n/a
Investing Cash Flow	-73.85M	12M	-9.62M	28.13M	-30.49M	-38K	-137K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	-314K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	120.02M	97.94M	61.07M	-5.61M	63.49M	38.98M	-7.37M
Financial Cash Flow	120.02M	97.94M	61.07M	-5.61M	63.49M	38.98M	-7.37M
Net Cash Flow	-35.03M	25.05M	9.25M	-5.29M	-6.78M	-784K	-84.18M
Free Cash Flow	-106.19M	-84.89M	-42.22M	-27.82M	-39.86M	-39.34M	-76.82M